| Name | Hanger Clinic |
|---|---|
| Organization Name | Hanger Prosthetics & Orthotics West Inc |
| Location | 5303 Spine Rd, Ste 201, Boulder, Colorado 80301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (303) 449-2245 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Wheelchair rugby and basketball players are aggressive, conditioned and determined, just like people without disabilities. Unlike them, though, is their likelihood of employment and economic independence. A new study from the University of Houston Department of Health and Human Performance (HHP) finds playing an adaptive sport can have dramatic results on the athlete and the economy.
Eating Recovery Center (www.eatingrecoverycenter.com), a behavioral hospital providing comprehensive treatment and sustainable recovery for eating disorders, this week announced that it has opened 12 new inpatient and residential beds to help meet an overwhelming demand for full spectrum eating disorder care.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U. S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds. One patent, US number 7,728,117, specifically covers GMI-1070, the Company's drug candidate now in clinical trials of patients with vaso-occlusive crisis of sickle cell disease. The second patent, US number 7,741,312, contains claims covering a family of molecules that includes and extends beyond GMI-1070.
The mysterious, highly infectious prions, which cause the severe destruction of the brain that characterizes "mad cow disease" and several human brain degenerative disorders, can be rendered harmless in the laboratory by a slight alternation of the three-dimensional conformation or shape of the prion protein's structure.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 5 days ago
| NPI Number | 1114091089 |
| Organization Name | HANGER PROSTHETICS & ORTHOTICS WEST INC |
| Doing Business As | HANGER CLINIC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5303 Spine Rd Ste 201, Boulder, CO 80301 |
| Phone Number | 303-449-2245 |
News Archive
Wheelchair rugby and basketball players are aggressive, conditioned and determined, just like people without disabilities. Unlike them, though, is their likelihood of employment and economic independence. A new study from the University of Houston Department of Health and Human Performance (HHP) finds playing an adaptive sport can have dramatic results on the athlete and the economy.
Eating Recovery Center (www.eatingrecoverycenter.com), a behavioral hospital providing comprehensive treatment and sustainable recovery for eating disorders, this week announced that it has opened 12 new inpatient and residential beds to help meet an overwhelming demand for full spectrum eating disorder care.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U. S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds. One patent, US number 7,728,117, specifically covers GMI-1070, the Company's drug candidate now in clinical trials of patients with vaso-occlusive crisis of sickle cell disease. The second patent, US number 7,741,312, contains claims covering a family of molecules that includes and extends beyond GMI-1070.
The mysterious, highly infectious prions, which cause the severe destruction of the brain that characterizes "mad cow disease" and several human brain degenerative disorders, can be rendered harmless in the laboratory by a slight alternation of the three-dimensional conformation or shape of the prion protein's structure.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 5 days ago
News Archive
Wheelchair rugby and basketball players are aggressive, conditioned and determined, just like people without disabilities. Unlike them, though, is their likelihood of employment and economic independence. A new study from the University of Houston Department of Health and Human Performance (HHP) finds playing an adaptive sport can have dramatic results on the athlete and the economy.
Eating Recovery Center (www.eatingrecoverycenter.com), a behavioral hospital providing comprehensive treatment and sustainable recovery for eating disorders, this week announced that it has opened 12 new inpatient and residential beds to help meet an overwhelming demand for full spectrum eating disorder care.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U. S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds. One patent, US number 7,728,117, specifically covers GMI-1070, the Company's drug candidate now in clinical trials of patients with vaso-occlusive crisis of sickle cell disease. The second patent, US number 7,741,312, contains claims covering a family of molecules that includes and extends beyond GMI-1070.
The mysterious, highly infectious prions, which cause the severe destruction of the brain that characterizes "mad cow disease" and several human brain degenerative disorders, can be rendered harmless in the laboratory by a slight alternation of the three-dimensional conformation or shape of the prion protein's structure.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 5 days ago
Cvs Pharmacy #16013 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2800 Pearl St, Boulder, Colorado 80301 Phone: (303) 209-0102 | |
King Soopers Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1650 30th St, Boulder, Colorado 80301 Phone: (303) 444-0164 | |
King Soopers Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6550 Lookout Rd, Boulder, Colorado 80301 Phone: (303) 530-0400 | |
Kroger Pharmacy #33 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3600 Table Mesa Dr, Boulder, Colorado 80305 Phone: (303) 499-4244 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5303 Spine Rd, Boulder, Colorado 80301 Phone: (303) 449-2245 |